Elicio Therapeutics (ELTX) Other Non-Current Assets (2021 - 2026)

Elicio Therapeutics (ELTX) has 6 years of Other Non-Current Assets data on file, last reported at $706000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 1.15% year-over-year to $706000.0; the trailing twelve-month figure through Mar 2026 stood at $706000.0 (up 1.15% YoY), and the FY2025 full-year result was $770000.0, up 28.33% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $706000.0, down from $770000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.8 million in Q4 2022 and bottomed at $75000.0 in Q3 2022.
• The 5-year median for Other Non-Current Assets is $706000.0 (2026), against an average of $1.2 million.
• The widest annual swing landed in 2023, when Other Non-Current Assets surged 3633.33%; it then sank 78.57% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $2.8 million in 2022, then dropped by 1.16% to $2.8 million in 2023, then tumbled by 78.57% to $600000.0 in 2024, then climbed by 28.33% to $770000.0 in 2025, then dropped by 8.31% to $706000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $706000.0 (Q1 2026), $770000.0 (Q4 2025), and $770000.0 (Q3 2025), per Business Quant data.

Peer Comparison